Clinical Trials on Refractory WHO Grade II Glioma in Japan
Total 7 results
-
Daiichi Sankyo Co., Ltd.Active, not recruiting
-
TakedaCompletedGrade I or II Essential HypertensionJapan
-
Sumitomo Pharma America, Inc.Active, not recruitingGlioblastoma Multiforme | High Grade GliomaUnited States, Japan
-
National Cancer Center, JapanOno Pharmaceutical Co. LtdRecruitingPancreatic Cancer | Low-grade GliomaJapan
-
Institut de Recherches Internationales ServierActive, not recruitingRecurrent Glioma | Grade 2 Glioma | Residual GliomaUnited States, Canada, Spain, Italy, United Kingdom, Switzerland, Israel, Japan, Netherlands, Germany, France
-
NRG OncologyNational Cancer Institute (NCI)RecruitingIntracranial Meningioma | Grade II MeningiomaCanada, United States, Japan, Saudi Arabia, India
-
Novartis PharmaceuticalsRecruitingMelanoma | Solid Tumor | High Grade Glioma | Non Small Cell Lung Cancer | Rare CancersSpain, Germany, United States, Argentina, Austria, Denmark, France, Hungary, Netherlands, China, Japan, Thailand